From February 4, 2024 to March 31, 2024, the company has repurchased 8,806,030 shares, representing 3.81% for CNY 75.3 million. With this, the company has completed the repurchase of 8,806,030 shares, representing 3.81% for CNY 75.3 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.12 CNY | -2.67% | -6.94% | -26.81% |
Jun. 03 | Xintian Pharmaceutical Gets Nod to Trial Chronic Non-Bacterial Prostatitis Drug; Shares Down 3% | MT |
May. 14 | Guiyang Xintian Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.81% | 275M | |
+19.60% | 80.67B | |
+13.63% | 9.17B | |
-15.14% | 4.86B | |
+45.17% | 4.55B | |
+15.70% | 4.34B | |
+14.68% | 2.38B | |
-26.13% | 2.2B | |
+15.73% | 2.1B | |
-40.52% | 1.86B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.